Kindly MD Stock (NASDAQ:NAKA)


RevenueFinancialsChart

Previous Close

$0.84

52W Range

$0.65 - $34.77

50D Avg

$3.23

200D Avg

$6.18

Market Cap

$379.88M

Avg Vol (3M)

$17.93M

Beta

-0.90

Div Yield

-

NAKA Company Profile


Kindly MD, Inc., a healthcare and healthcare data company, provides direct health care services to patients integrating prescription medicine and behavioral health services. The company offers specialty outpatient clinical services based on a subscription and fee-for-service basis to augment traditional healthcare. It provides evaluation and management services, including chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support, overdose education, peer support, limited urgent care, preventative medicine, travel, and hormone therapy; and data collection and research, and online and email campaign marketing services, as well as engages in the retail sale of health care products through clinics and online. Kindly MD, Inc. was formerly known as Utah Therapeutic Health Center, LLC and changed its name to Kindly MD, Inc. in March 2022. The company was incorporated in 2019 and is based in Salt Lake City, Utah.

Show More

Industry

Medical - Equipment & Services

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

23

IPO Date

May 31, 2024

Website

NAKA Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 24
Product Retail Sales$71.71K

Fiscal year ends in Dec 24 | Currency in USD

NAKA Financial Summary


Dec 24Dec 23Dec 22
Revenue$2.72M$3.77M$3.79M
Operating Income$-3.35M$-1.62M$-2.69M
Net Income$-3.62M$-1.62M$-2.54M
EBITDA$-3.00M$-1.36M$-2.42M
Basic EPS$-0.67$-0.27$-0.43
Diluted EPS$-0.67$-0.27$-0.43

Fiscal year ends in Dec 24 | Currency in USD

Peer Comparison


TickerCompany
LFMDLifeMD, Inc.
BLRXBioLineRx Ltd.
MASS908 Devices Inc.
ALLOAllogene Therapeutics, Inc.
NMRANeumora Therapeutics, Inc. Common Stock
TBRGTruBridge, Inc.
KYTXKyverna Therapeutics, Inc.
SOPHSOPHiA GENETICS S.A.
DHDefinitive Healthcare Corp.
VYGRVoyager Therapeutics, Inc.